Kestra Medical Technologies (KMTS) earnings
In the quarter ended July 2026, Kestra Medical Technologies had revenue of $31M, up 59.9% on a year earlier, and diluted EPS of -0.75.
On September 14, 2026 it reported EPS of -0.75 against an estimate of -0.61 (missed).
Report dates
| Report | Date | Time | EPS estimate | EPS reported |
|---|---|---|---|---|
| Last | Mon Sep 14, 2026 | — | -0.61 | -0.75 |
Dates from company announcements and exchange calendars; estimates are the consensus where available. See the full earnings calendar.
Quarterly results
The last 9 quarters from Kestra Medical Technologies's 10-Q and 10-K filings with the SEC. Growth is against the same quarter a year earlier. EPS here is GAAP diluted EPS as filed; the reported EPS compared with estimates above can be on the company's adjusted basis, so the two can differ.
| Quarter ended | Revenue | Growth | EPS (diluted) | Growth | Op. margin | Filed |
|---|---|---|---|---|---|---|
| Jul 31, 2026 | $31M | +59.9% | -0.75 | — | -121.6% | 2026-09-14 |
| Apr 30, 2026 | $29M | +66.2% | — | — | -137.4% | 2026-07-14 |
| Jan 31, 2026 | $25M | +62.7% | -0.61 | — | -141.6% | 2026-03-17 |
| Oct 31, 2025 | $23M | +53.4% | -0.64 | — | -140.7% | 2025-12-11 |
| Jul 31, 2025 | $19M | +51.5% | -0.50 | — | -149.1% | 2025-09-12 |
| Apr 30, 2025 | $17M | — | — | — | -279.8% | 2025-07-17 |
| Jan 31, 2025 | $15M | — | -1.25 | — | -136.5% | 2026-03-17 |
| Oct 31, 2024 | $15M | — | -1.19 | — | -130.1% | 2025-12-11 |
| Jul 31, 2024 | $13M | — | -1.12 | — | -144.2% | 2025-09-12 |
Questions
How did Kestra Medical Technologies do last quarter?
In the quarter ended July 2026, Kestra Medical Technologies had revenue of $31M, up 59.9% on a year earlier, and diluted EPS of -0.75.
From Kestra Medical Technologies's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.